| Clinical data | |
|---|---|
| Other names | 4-(2-Aminopropyl)-1-benzothiophene |
| Drug class | Serotonin–norepinephrine–dopamine releasing agent |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C11H13NS |
| Molar mass | 191.29 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-APBT, also known as4-(2-aminopropyl)-1-benzothiophene, is amonoamine releasing agent (MRA) of theamphetamine andbenzothiophene families.[1][2] It acts specifically as a fairly well-balancedserotonin–norepinephrine–dopamine releasing agent (SNDRA), withEC50Tooltip half-maximal effective concentration values of 21.2 nM forserotonin, 46.2 nM fornorepinephrine, and 66.6 nM fordopamine in rat brainsynaptosomes.[2] 4-APBT was first described in thescientific literature by 2020.[1][2]
Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |